Thursday, May 03, 2018 10:17:54 AM
Most of these articles and conferences are paid for or sponsored by USRM to promote the cottage industry they are creating. They know they are operating in the Wild West of medical science and are milking it for all it’s worth while it isn’t regulated.
She is very intelligent and, as one poster said, may have “golden hands”, but the current hype is all of their own making and targeting to very specific populations who are desperate to try anything.
Testimonials aren’t enough. They are meaningless as true results could be easily quantifiable and measured by before and after imaging showing remodeling at the cellular level. Placebo until they can prove otherwise.
If they can prove it, they will change everything. Not before then. Sure, the stock price can move up on financials, but until they can demonstrate actual efficacy of their methods they will remain on the outside.
Show me something real USRM.
all of this is speculative and my opinion only. not investment advice.
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM